Zhu J B, Koizumi T
Faculty of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University, Japan.
J Pharmacobiodyn. 1987 Aug;10(8):370-6. doi: 10.1248/bpb1978.10.370.
Furosemide disposition in man was studied. Six male young healthy volunteers were given 20 mg furosemide by bolus intravenous injection and 10, 20, 30 and 40 mg furosemide (solution) orally. The serum drug concentration was determined by high performance liquid chromatography and the urinary excretion was determined spectrophotometrically after diazotization. The experimental data from serum and urine samples were simultaneously subjected to computer analysis. On the basis of the results, it was demonstrated that disposition of furosemide in man can be described by a two-compartment open model with the following average parameters: t1/2 alpha = 0.237 +/- 0.069 h, t1/2 beta = 1.29 +/- 0.20 h and Vss = 8.46 +/- 2.171. After oral administration of furosemide solution, the drug was rapidly absorbed from the gastrointestinal tract with a first-order absorption rate constant ka of 2.33 +/- 0.93 h-1 but there was a lag time of about 6.45 min for drug resolution and entering the absorption site. The oral relative bioavailability was estimated as 83 +/- 14%, which was higher than reported values. The elimination of furosemide was very rapid and was mainly via the renal route. The systemic clearance (CLs) and renal clearance (CLr), following bolus intravenous dosing were 7.60 +/- 2.29 and 6.44 +/- 1.81 l/h, respectively. The oral route did not influence CLs and CLr on the whole, but the nonrenal clearance ratio (CRnr) after oral dosing (15.7 +/- 4.8%) was significantly higher than that after intravenous administration (11.2 +/- 4.0%), which can be explained by a first-pass effect of the liver-portal system.
对呋塞米在人体中的处置情况进行了研究。六名年轻健康男性志愿者接受了静脉推注20毫克呋塞米,并分别口服10、20、30和40毫克呋塞米(溶液)。采用高效液相色谱法测定血清药物浓度,重氮化后用分光光度法测定尿排泄量。血清和尿液样本的实验数据同时进行计算机分析。根据结果表明,呋塞米在人体中的处置情况可用二室开放模型描述,其平均参数如下:t1/2α = 0.237±0.069小时,t1/2β = 1.29±0.20小时,Vss = 8.46±2.171。口服呋塞米溶液后,药物从胃肠道迅速吸收,一级吸收速率常数ka为2.33±0.93 h-1,但药物溶解并进入吸收部位约有6.45分钟的滞后时间。口服相对生物利用度估计为83±14%,高于报道值。呋塞米的消除非常迅速,主要通过肾脏途径。静脉推注给药后的全身清除率(CLs)和肾清除率(CLr)分别为7.60±2.29和6.44±1.81升/小时。口服途径总体上不影响CLs和CLr,但口服给药后的非肾清除率(CRnr)(15.7±4.8%)显著高于静脉给药后的(11.2±4.0%),这可以用肝门静脉系统的首过效应来解释。